Morteza Nadjafi, MD, FAPA — Orlando, Florida

Morteza Nadjafi, MD, FAPA is a clinical research site located in Orlando, Florida, United States 32803.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Morteza Nadjafi, MD, FAPA has participated in 1 clinical trials.

Therapeutic areas: Attention-Deficit/Hyperactivity Disorder.

Sponsors: Shire.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Morteza Nadjafi, MD, FAPA?

Morteza Nadjafi, MD, FAPA has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Morteza Nadjafi, MD, FAPA conducted?

Morteza Nadjafi, MD, FAPA has 1 clinical trials on record. Their work covers Attention-Deficit/Hyperactivity Disorder.

Is Morteza Nadjafi, MD, FAPA accredited by Crixeo Health?

Morteza Nadjafi, MD, FAPA has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Morteza Nadjafi, MD, FAPA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.